bluebird bio (NASDAQ:BLUE) Shares Down 2.8% Following Analyst Downgrade
bluebird bio, Inc. (NASDAQ:BLUE - Get Free Report)'s share price traded down 2.8% during trading on Tuesday after Wedbush lowered...
bluebird bio, Inc. (NASDAQ:BLUE - Get Free Report)'s share price traded down 2.8% during trading on Tuesday after Wedbush lowered...
Apple has agreed to pay $490 million to settle a class-action lawsuit alleging CEO Tim Cook misled investors about a...
Shares of BigBear.ai Holdings, Inc. (NYSE:BBAI - Get Free Report) fell 6.6% on Monday . The company traded as low...
Assured Guaranty Ltd. (NYSE:AGO - Get Free Report) saw a large decrease in short interest during the month of February....
Tutor Perini (NYSE:TPC - Get Free Report) was downgraded by StockNews.com from a "buy" rating to a "hold" rating in...
Symbotic Inc. (NASDAQ:SYM - Get Free Report) shares fell 2% on Monday . The company traded as low as $43.81...
Shares of Beyond Meat Inc. BYND, -2.24% shed 2.24% to $8.31 Monday, on what proved to be an all-around great...
SoFi Technologies, Inc. (NASDAQ:SOFI - Get Free Report) shares traded down 0.9% during mid-day trading on Monday . The company...
NEW YORK >> Best Buy is recalling more than 287,000 air fryers and air fryer ovens due to an overheating...
StockNews.com lowered shares of Ingredion (NYSE:INGR - Free Report) from a strong-buy rating to a buy rating in a report...
Get breaking news delivered straight into your inbox
Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Rotten Tomato stocks is a wholly-owned subsidiary of Grainne Capital Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
© Copyright 2023 RottenTomatoStocks. All Rights Reserved